These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Different dosages of intravenous immunoglobulin (IVIg) in treating immune thrombocytopenia with long-term follow-up of three years: Results of a prospective study including 167 cases. Zhou Z, Qiao Z, Li H, Luo N, Zhang X, Xue F, Yang R. Autoimmunity; 2016; 49(1):50-7. PubMed ID: 26525513 [Abstract] [Full Text] [Related]
6. Idiopathic thrombocytopenic purpura: a 10-year natural history study at the childrens hospital of alabama. Watts RG. Clin Pediatr (Phila); 2004 Oct; 43(8):691-702. PubMed ID: 15494875 [Abstract] [Full Text] [Related]
7. Evaluation of IVIG response in relation to Th1/Th2 cytokines in pediatricm immune thrombocytopenia. Chen YY, Zhou YQ, Zhao N, Zhang Y, Xu WQ, Tang YM. Cytokine; 2019 Aug; 120():234-241. PubMed ID: 31129375 [Abstract] [Full Text] [Related]
8. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur. Ou CY, Hsieh KS, Chiou YH, Chang YH, Ger LP. Acta Paediatr Taiwan; 2006 Aug; 47(5):226-31. PubMed ID: 17352309 [Abstract] [Full Text] [Related]
10. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia. Zeller MP, Heddle NM, Kelton JG, Hamilton K, Wang G, Sholapur N, Carruthers J, Hsia C, Blais N, Toltl L, Hamm C, Pearson MA, Arnold DM. Transfusion; 2016 Jan; 56(1):73-9. PubMed ID: 26400824 [Abstract] [Full Text] [Related]
12. First Line Treatments for Newly Diagnosed Primary Immune Thrombocytopenia in Children: A Systematic Review and Network Meta-analysis. Acero-Garcés DO, García-Perdomo HA. Curr Pediatr Rev; 2020 Jan; 16(1):61-70. PubMed ID: 31656149 [Abstract] [Full Text] [Related]
13. Retrospective evaluation of children with immune thrombocytopenic purpura and factors contributing to chronicity. Güngör T, Arman Bilir Ö, Koşan Çulha V, Güngör A, Kara A, Azık FM, Yaralı HN. Pediatr Neonatol; 2019 Aug; 60(4):411-416. PubMed ID: 30470618 [Abstract] [Full Text] [Related]
14. The effect of ABO and Rh blood type on the response to intravenous immune globulin (IVIG) in children with immune thrombocytopenic purpura (ITP). Sturgill MG, Nagabandi SR, Drachtman RA, Ettinger AG, Rubin J, Ettinger LJ. J Pediatr Hematol Oncol; 1997 Aug; 19(6):523-5. PubMed ID: 9407938 [Abstract] [Full Text] [Related]
16. Treatment, outcome, and cost of care in children with idiopathic thrombocytopenic purpura. Kumar M, Vik TA, Johnson CS, Southwood ME, Croop JM. Am J Hematol; 2005 Mar; 78(3):181-7. PubMed ID: 15726607 [Abstract] [Full Text] [Related]
17. Clinical outcome of childhood chronic immune thrombocytopenia: A 38-year experience from a single tertiary center in Thailand. Chotsampancharoen T, Sripornsawan P, Duangchoo S, Wongchanchailert M, McNeil E. Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28453897 [Abstract] [Full Text] [Related]
18. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Tarantino MD, Young G, Bertolone SJ, Kalinyak KA, Shafer FE, Kulkarni R, Weber LC, Davis ML, Lynn H, Nugent DJ, Acute ITP Study Group. J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411 [Abstract] [Full Text] [Related]